TransGenRx based in Baton Rouge plans to begin manufacturing protein-based drugs in Europe over the next two years.
For more solutions please try www.hazeng.com or www.engineeringtrader.com
More Editorial
Directory
This website is owned and operated by: MSL Media Limited
Co. Number: 05359182
© 2005 MSL Media Ltd. All rights reserved. E&OE
